/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the Redeye Orphan Drugs Conference on April 27, 2022. CEO.
/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will participate at the Kempen Life Sciences Conference, April 21. More.
/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR) today announces that the Annual Report for 2021 now is available at the company s website: www.medivir.com..
/PRNewswire/ The shareholders of Medivir AB (publ), reg. no. 556238-4361, with its registered office in Huddinge, Stockholm, are hereby summoned to the.